申请人:Merck & Co., Inc.
公开号:US06248755B1
公开(公告)日:2001-06-19
The present invention is directed to pyrrolidine compounds of the formula I:
(wherein R1, R2, R3, R4, R5, R6, R14 and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.
本发明涉及式I的吡咯烷化合物:
(其中R1,R2,R3,R4,R5,R6,R14和n的定义如本文中)这些化合物可用作调节化学趋化因子受体活性的调节剂。特别是,这些化合物可用作调节CCR-5和/或CCR-3的化学趋化因子受体的调节剂。